NEW YORK (GenomeWeb News) – Oxford Genome Sciences today said that it has changed its name to Oxford BioTherapeutics.
 
The Oxford, UK-based firm said the name change comes as it focuses its efforts on the development of its pipeline of antibody-based cancer therapeutics. The firm also has a collaboration with diagnostics firm Biosite to develop companion diagnostics for its cancer therapeutics.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.